Terms: = Lymphoma AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Prognosis
118 results:
1. The role of α7-nAChR-mediated PI3K/AKT pathway in lung cancer induced by nicotine.
He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
[TBL] [Abstract] [Full Text] [Related]
2. [New treatment strategies for primary lymphoma of the central nervous system].
Seidel S; Kaulen L; von Baumgarten L
Nervenarzt; 2024 Feb; 95(2):117-124. PubMed ID: 37910181
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mtor signaling pathway.
Gao G; Xue Q; He J; Wu M; Jiang Y; Li Q; Zhang Y; Shi W
Int Immunopharmacol; 2023 Dec; 125(Pt A):111125. PubMed ID: 37907047
[TBL] [Abstract] [Full Text] [Related]
4. Acquired resistance to crizotinib in novel CDK14-ALK and CLTC-ALK fusions of ALK-positive large B-cell lymphoma identified by next-generation sequencing.
Xia Y; Zhang L; He W; Pan H; Fang J; Cui G
Cancer Biol Ther; 2023 Dec; 24(1):2271212. PubMed ID: 37906510
[TBL] [Abstract] [Full Text] [Related]
5. Resistance to PRMT5-targeted therapy in mantle cell lymphoma.
Long ME; Koirala S; Sloan S; Brown-Burke F; Weigel C; Villagomez L; Corps K; Sharma A; Hout I; Harper M; Helmig-Mason J; Tallada S; Chen Z; Scherle P; Vaddi K; Chen-Kiang S; Di Liberto M; Meydan C; Foox J; Butler D; Mason C; Alinari L; Blaser BW; Baiocchi R
Blood Adv; 2024 Jan; 8(1):150-163. PubMed ID: 37782774
[TBL] [Abstract] [Full Text] [Related]
6. XBP1 promotes NRAS
Salimi A; Schemionek-Reinders M; Huber M; Vieri M; Patterson JB; Alten J; Brümmendorf TH; Kharabi Masouleh B; Appelmann I
J Cell Mol Med; 2023 Nov; 27(21):3363-3377. PubMed ID: 37753803
[TBL] [Abstract] [Full Text] [Related]
7. High
Salwa A; Ferraresi A; Secomandi E; Vallino L; Moia R; Patriarca A; Garavaglia B; Gaidano G; Isidoro C
Cells; 2023 Jul; 12(15):. PubMed ID: 37566004
[TBL] [Abstract] [Full Text] [Related]
8. SHIP1 Is Present but Strongly Downregulated in T-ALL, and after Restoration Suppresses Leukemia Growth in a T-ALL Xenotransplantation Mouse Model.
Ehm P; Rietow R; Wegner W; Bußmann L; Kriegs M; Dierck K; Horn S; Streichert T; Horstmann M; Jücker M
Cells; 2023 Jul; 12(13):. PubMed ID: 37443832
[TBL] [Abstract] [Full Text] [Related]
9. Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.
Villa-Morales M; Pérez-Gómez L; Pérez-Gómez E; López-Nieva P; Fernández-Navarro P; Santos J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373496
[TBL] [Abstract] [Full Text] [Related]
10. ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming.
Zhang ZJ; Wu QF; Ren AQ; Chen Q; Shi JZ; Li JP; Liu XY; Zhang ZJ; Tang YZ; Zhao Y; Yao NN; Zhang XY; Liu CP; Dong G; Zhao JX; Xu MJ; Yue YQ; Hu J; Sun F; Liu Y; Ao QL; Zhou FL; Wu H; Zhang TC; Zhu HC
Acta Pharmacol Sin; 2023 Nov; 44(11):2282-2295. PubMed ID: 37280363
[TBL] [Abstract] [Full Text] [Related]
11. De novo missense variants in RRAGC lead to a fatal mtoropathy of early childhood.
Reijnders MRF; Seibt A; Brugger M; Lamers IJC; Ott T; Klaas O; Horváth J; Rose AMS; Craghill IM; Brunet T; Graf E; Mayerhanser K; Hellebrekers D; Pauck D; Neuen-Jacob E; Rodenburg RJT; Wieczorek D; Klee D; Mayatepek E; Driessen G; Bindermann R; Averdunk L; Lohmeier K; Sinnema M; Stegmann APA; Roepman R; Poulter JA; Distelmaier F
Genet Med; 2023 Jul; 25(7):100838. PubMed ID: 37057673
[TBL] [Abstract] [Full Text] [Related]
12. Identification of biomarkers of hepatocellular carcinoma gene prognosis based on the immune-related lncRNA signature of transcriptome data.
Ma A; Sun Y; Ogbodu RO; Xiao L; Deng H; Zhou H
Funct Integr Genomics; 2023 Mar; 23(2):104. PubMed ID: 36976410
[TBL] [Abstract] [Full Text] [Related]
13. HIF-1α mediates CXCR4 transcription to activate the AKT/mtor signaling pathway and augment the viability and migration of activated B cell-like diffuse large B-cell lymphoma cells.
Jin Z; Xiang R; Dai J; Wang Y; Xu Z
Mol Carcinog; 2023 May; 62(5):676-684. PubMed ID: 36789975
[TBL] [Abstract] [Full Text] [Related]
14. Targeting positive cofactor 4 induces autophagic cell death in MYC-expressing diffuse large B-cell lymphoma.
Ma L; Gong Q; Chen Y; Luo P; Chen J; Shi C
Exp Hematol; 2023; 119-120():42-57.e4. PubMed ID: 36642374
[TBL] [Abstract] [Full Text] [Related]
15. Marine Sponge-Derived Alkaloid Induces Mitochondrial Dysfunction and Inhibits the PI3K/AKT/mtor Signaling Pathway against Burkitt's lymphoma.
Zhao HM; He J; Chang YT; Liu LY; Sun F; Lin HW; Yang F
J Nat Prod; 2023 Jan; 86(1):45-51. PubMed ID: 36524671
[TBL] [Abstract] [Full Text] [Related]
16. Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma.
Ma G; Gao Y; Jing X; He C; Liu H; Wu X; Gao Z; Li Y; Zhang S; Zhao G
Leuk Lymphoma; 2023 Jan; 64(1):140-150. PubMed ID: 36215154
[TBL] [Abstract] [Full Text] [Related]
17. The effects of REG4 expression on chemoresistance of ovarian cancer.
Xiang LW; Xue H; Ha MW; Yu DY; Xiao LJ; Zheng HC
J Obstet Gynaecol; 2022 Oct; 42(7):3149-3157. PubMed ID: 35929918
[TBL] [Abstract] [Full Text] [Related]
18. RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia.
Pham LT; Peng H; Ueno M; Kohno S; Kasada A; Hosomichi K; Sato T; Kurayoshi K; Kobayashi M; Tadokoro Y; Kasahara A; Shoulkamy MI; Xiao B; Worley PF; Takahashi C; Tajima A; Hirao A
Biochem Biophys Res Commun; 2022 Sep; 621():74-79. PubMed ID: 35810594
[TBL] [Abstract] [Full Text] [Related]
19. Identification of CXCR4 Upregulation in Diffuse Large B-Cell lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics.
Zhang YA; Yang X; Yao J; Ren Y; Liu P
Dis Markers; 2022; 2022():3276925. PubMed ID: 35774848
[TBL] [Abstract] [Full Text] [Related]
20. KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry.
Gong Y; Zhou L; Ding L; Zhao J; Wang Z; Ren G; Zhang J; Mao Z; Zhou R
Medicine (Baltimore); 2022 Jun; 101(24):e29312. PubMed ID: 35713434
[TBL] [Abstract] [Full Text] [Related]
[Next]
